Angiotensin II Receptor Blockers

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • January 22, 2021; December 2018; December 2016; October 2014; December 2012; March 2011; April 2008; July 2003; July 2002; September 2001; September 2000; July 1999; June 1998; July 1997; December 1996
  • Initially developed
    • April 1996